Cellnex Telecom S.A. (0R9C)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 25.93 |
|---|---|
| 52-week range | 21.85 – 32.62 |
| Return, 1 month / 3 months | +2.0% / +4.1% |
| Return, 1 year / 3 years | −8.1% / −2.6% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -31.0% |
| Average daily value traded | 4.90M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cellnex Telecom is a Spanish telecommunications infrastructure company based in Barcelona. It owns and operates wireless infrastructure, chiefly mobile phone towers and related sites, and leases space on that infrastructure to mobile network operators and other wireless carriers. Its customers are telecom operators that need antenna sites and related services to run their networks, and the company operates across several European countries. Cellnex also provides services connected with small cells, distributed antenna systems and fibre links.
The shares are listed on the London Exchange in UK under the code 0R9C, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cellnex Telecom S.A. (0R9C) trades on the London Exchange in UK. It last closed at EUR 25.93 on 22 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 2,004 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.1% and over the last three months it rose 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.6% | ||
| From 52-week high | -19.8% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 4.1% | ||
| 6-month return | -7.9% | ||
| 12-month return, skipping the last month | -9.9% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.0% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.90M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +2.0% |
| 3 months | +4.1% |
| 6 months | −7.9% |
| 1 year | −8.1% |
| 3 years | −2.6% |
| 5 years | −50.8% |
Signals
| 50-day / 200-day average | 25.15 / 26.89 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | EUR 0.3769 |
| 13 Jan 2026 | EUR 0.3710 |
| 16 Jun 2025 | EUR 0.0167 |
| 19 Nov 2024 | EUR 0.0460 |
| 13 Jun 2024 | EUR 0.0168 |
| 21 Nov 2023 | EUR 0.0404 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.